Serious infection after acute myocardial infarction: incidence, clinical features, and outcomes.

ABSTRACT:

Objectives

The aim of this study was to address the knowledge gap using the APEX-AMI (Assessment of Pexelizumab in Acute Myocardial Infarction) trial database. We also assessed the association between serious infections and 90-day death or death/myocardial infarction (MI).

Background

Little is known about the incidence, location, etiological organisms, and outcomes of infection in patients with ST-segment elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention.

Methods

We analyzed data from 5,745 STEMI patients enrolled in the APEX-AMI trial. Detailed information on infection was collected for all patients. We described characteristics of patients according to infection and details of infection. Cox proportional hazards models w

SUBMITTER: Truffa AA 

PROVIDER: S-EPMC3883036 | biostudies-literature | 2012 Jul

REPOSITORIES: biostudies-literature